Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
Clasificación en acciones #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Precio por acción
$11.14
Última sincronización: 2023-11-28
Capitalización bursátil
$160.14M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Monterey Bio Acquisition Corporation (MTRY)
Historial de rendimiento por dividendo de Monterey Bio Acquisition Corporation (MTRY)
Rendimiento por dividendo (TTM) de Monterey Bio Acquisition Corporation (símbolo bursátil: MTRY) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Monterey Bio Acquisition Corporation (MTRY) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras